Recently, the Ministry of science and technology announced the key special funded projects of the national key R & D plan in 2022, and Chengdu Shilian Health Biotechnology Co., Ltd. was approved two sub projects under the key special project of the national key R & D plan "stem cell research and organ repair"! They are the special sub projects of "Research on standardized preparation and quality detection system of dental stem cells" and "Research on engineering technology of dental biological reconstruction and in situ regeneration".
Two sub projects of the national key R & D plan
|
Serial number |
Special projects |
Project name |
type |
Person in charge |
|
1 |
Stem cell research and organ repair |
Study on standardized preparation and quality detection system of dental stem cells |
Sub topic |
Tangyingfeng |
|
2 |
Stem cell research and organ repair |
Study on the engineering technology of dental reconstruction and in situ regeneration |
Sub topic |
Zhang Jingyi |
Worldlink health group is able to undertake two sub projects of national key R & D projects this time, which is a concentrated reflection of the company's scientific research ability and innovation ability, and also a milestone step in promoting the research and development of cell drugs and the transformation and application of cell therapy.
National key R & D plan
The national key R & D plan is an integration of the original national key basic research and development plan (973 Plan), the national high technology research and development plan (863 plan), the national science and technology support plan, and international science and technology cooperation and exchange projects. It mainly focuses on major social public welfare research related to the national economy and the people's livelihood, as well as major scientific and technological issues related to the core competitiveness of the industry, the overall independent innovation ability and national security, breaking through the technical bottleneck in the main fields of national economy and social development.
The overall goal of the key special project of "stem cell research and organ repair" participated by WorldUnion health group is to focus on the key scientific issues of stem cell development and organ regeneration, carry out basic theory and key technology research on stem cell fate regulation, organ formation and aging mechanism, organ function remodeling and manufacturing, gene editing and regulation methods, human disease stem cell model, and carry out organ regeneration regulation drugs, bioartificial organs Frontier explorations such as disease organoid models provide innovative theories and technologies for the repair and replacement of important tissues and organs and the diagnosis and treatment of major diseases.
Chengdu Shilian Health Biotechnology Co., Ltd. was jointly founded by West China Hospital, West China stomatological hospital and West China second hospital. It is a platform for the research, development and transformation of cell technology and cell drugs. Relying on the powerful R & D platform of century West China, it includes "national local joint engineering laboratory", "National Precision medicine industry innovation center", "Engineering Research Center of the Ministry of oral translational medicine education" and "State Key Laboratory of oral disease research". In terms of cellular drug research and development, WorldUnion health group launched the world's first clinical study of dental follicle stem cells in the treatment of periodontal disease. This undertaking of two special sub projects of the national key R & D plan is both strength and mission, and it is also the vision of the company to "build the highest level one-stop cell industry innovation platform of the whole chain in China".
